•
Sep 30, 2022

Pliant Therapeutics Q3 2022 Earnings Report

Total Revenue
$1.48M
Previous year: $1.61M
-8.0%
EPS
-$0.65
Previous year: -$0.75
-13.3%
Gross Profit
$452K
Previous year: $1.21M
-62.6%
Cash and Equivalents
$44.6M
Previous year: $45.2M
-1.4%
Free Cash Flow
-$19.2M
Previous year: -$23M
-16.5%
Total Assets
$377M
Previous year: $234M
+61.1%

Pliant Therapeutics

Pliant Therapeutics